The Food and Drug Administration (FDA) has approved Khindivi ™ (hydrocortisone) oral solution as a replacement therapy in ...

Early improvements in OSDI scores and tear osmolarity reinforce lifitegrast’s role in managing inflammation-driven dry eye ...

Thirst is a crucial physiological signal that contributes to the survival of humans and other animals, by allowing them to ...

A significant proportion of cataract surgery patients exhibit hyperosmolar tear film both before and 1 month after surgery, ...

In addition to a comprehensive ophthalmological examination, tear osmolarity measurements were taken for both eyes. Participants were also administered the Ocular Surface Disease Index (OSDI) ...

Optician recently hosted a webinar on Building the Dry Eye Clinic of the Future. Chair Chris Bennett asked the speakers to ...

KHINDIVI is the first and only FDA-approved hydrocortisone oral solution • Commercial launch expected the week of June 2 nd • ...

Learn which drugs can cause dry eye disease, and what to do if you’re taking a medication that can cause dry eye symptoms.

The overall research objective of my group is to combine novel cell scaffold development with mechanical cues to direct and guide tissue growth in the appropriate composition to yield a functional and ...

Eton Pharmaceuticals, Inc (“Eton” or“the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced the U.S.